Real-World Impact of Once-Weekly Injectable Semaglutide (sema OW) Vs. Sodium-Glucose Cotransporter 2 Inhibitors (sglt2i) on HbA1c, Weight, and Health Care Resource Utilization (HCRU) Outcomes in Type 2 Diabetes (T2d)-an Observational Study (PAUSE)
DIABETES（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined